_id
690db47dccc777a4e85d0d57
Ticker
AZTA
Name
Azenta Inc
Exchange
NASDAQ
Address
200 Summit Drive, Burlington, MA, United States, 01803
Country
USA
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
USD
Website
https://www.azenta.com
Description
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
Last Close
37.5
Volume
1236191
Current Price
35.3
Change
-5.866666666666674
Last Updated
2025-11-28T12:39:47.839Z
Image
data:image/webp;base64,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
Ipo Date
1995-02-02T00:00:00.000Z
Market Cap
1663305216
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8920090909090909
Sentiment Sources
33
Rating
3.4286
Target Price
39.8333
Strong Buy
1
Buy
1
Hold
5
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
159192000
Cost Of Revenue
86918000
Gross Profit
72274000
Operating Expenses
70373000
Operating Income
1901000
Interest Expense
-
Pretax Income
6300000
Net Income
47137000
Eps
1.0248510675305476
Dividends Per Share
-
Shares Outstanding
45858979
Income Tax Expense
-44553000
EBITDA
1901000
Operating Margin
1.1941554852002612
Total Other Income Expense Net
4399000
Cash
279783000
Short Term Investments
61137000
Receivables
142181000
Inventories
74956000
Total Current Assets
709634000
Property Plant Equipment
208002000
Total Assets
2056854000
Payables
37722000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
333608000
Equity
1723246000
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
PE
69.75
PB
0.9421685586387549
ROE
2.735361056981998
ROA
2.2917037378443
FCF
-
Fcf Percent
-
Piotroski FScore
2
Health Score
61
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
3.5
Growth Investing Score
2
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
5
Value Investing Score
7.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
159192000
Quarters > 0 > income Statement > cost Of Revenue
86918000
Quarters > 0 > income Statement > gross Profit
72274000
Quarters > 0 > income Statement > operating Expenses
70373000
Quarters > 0 > income Statement > operating Income
1901000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
6300000
Quarters > 0 > income Statement > net Income
47137000
Quarters > 0 > income Statement > eps
1.0248510675305476
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
45994000
Quarters > 0 > income Statement > income Tax Expense
-44553000
Quarters > 0 > income Statement > EBITDA
1901000
Quarters > 0 > income Statement > operating Margin
1.1941554852002612
Quarters > 0 > income Statement > total Other Income Expense Net
4399000
Quarters > 0 > balance Sheet > cash
279783000
Quarters > 0 > balance Sheet > short Term Investments
61137000
Quarters > 0 > balance Sheet > receivables
142181000
Quarters > 0 > balance Sheet > inventories
74956000
Quarters > 0 > balance Sheet > total Current Assets
709634000
Quarters > 0 > balance Sheet > property Plant Equipment
208002000
Quarters > 0 > balance Sheet > total Assets
2056854000
Quarters > 0 > balance Sheet > payables
37722000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
333608000
Quarters > 0 > balance Sheet > equity
1723246000
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > ratios > PE
1.0248510675305476
Quarters > 0 > ratios > PB
0.9421685586387549
Quarters > 0 > ratios > ROE
2.735361056981998
Quarters > 0 > ratios > ROA
2.2917037378443
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
61
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
143942000
Quarters > 1 > income Statement > cost Of Revenue
76182000
Quarters > 1 > income Statement > gross Profit
67760000
Quarters > 1 > income Statement > operating Expenses
68474000
Quarters > 1 > income Statement > operating Income
-714000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
3438000
Quarters > 1 > income Statement > net Income
-52806000
Quarters > 1 > income Statement > eps
-1.1551890094504724
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
45712000
Quarters > 1 > income Statement > income Tax Expense
2758000
Quarters > 1 > income Statement > EBITDA
18028000
Quarters > 1 > income Statement > operating Margin
-0.49603312445290465
Quarters > 1 > income Statement > total Other Income Expense Net
4152000
Quarters > 1 > balance Sheet > cash
270040000
Quarters > 1 > balance Sheet > short Term Investments
48817000
Quarters > 1 > balance Sheet > receivables
124535000
Quarters > 1 > balance Sheet > inventories
80506000
Quarters > 1 > balance Sheet > total Current Assets
678478000
Quarters > 1 > balance Sheet > property Plant Equipment
214301000
Quarters > 1 > balance Sheet > total Assets
2019135000
Quarters > 1 > balance Sheet > payables
37984000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
345501000
Quarters > 1 > balance Sheet > equity
1673634000
Quarters > 1 > cash Flow > net Income
680000
Quarters > 1 > cash Flow > depreciation
14722000
Quarters > 1 > cash Flow > change In Working Capital
10791000
Quarters > 1 > cash Flow > cash From Operations
25810000
Quarters > 1 > cash Flow > capital Expenditures
10839000
Quarters > 1 > cash Flow > cash From Investing
-29701000
Quarters > 1 > cash Flow > cash From Financing
-128000
Quarters > 1 > cash Flow > net Change In Cash
16608000
Quarters > 1 > ratios > PE
-1.1551890094504724
Quarters > 1 > ratios > PB
0.9641496288913823
Quarters > 1 > ratios > ROE
-3.155170126801917
Quarters > 1 > ratios > ROA
-2.615278324629111
Quarters > 1 > ratios > FCF
14971000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.10400716955440385
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
143418000
Quarters > 2 > income Statement > cost Of Revenue
77532000
Quarters > 2 > income Statement > gross Profit
65886000
Quarters > 2 > income Statement > operating Expenses
82037000
Quarters > 2 > income Statement > operating Income
-16151000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-10505000
Quarters > 2 > income Statement > net Income
-40456000
Quarters > 2 > income Statement > eps
-0.8846322050205545
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
45732000
Quarters > 2 > income Statement > income Tax Expense
7680000
Quarters > 2 > income Statement > EBITDA
1382000
Quarters > 2 > income Statement > operating Margin
-11.261487400465771
Quarters > 2 > income Statement > total Other Income Expense Net
5646000
Quarters > 2 > balance Sheet > cash
253642000
Quarters > 2 > balance Sheet > short Term Investments
74697000
Quarters > 2 > balance Sheet > receivables
149490000
Quarters > 2 > balance Sheet > inventories
83321000
Quarters > 2 > balance Sheet > total Current Assets
710596000
Quarters > 2 > balance Sheet > property Plant Equipment
211572000
Quarters > 2 > balance Sheet > total Assets
2041925000
Quarters > 2 > balance Sheet > payables
39155000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
340433000
Quarters > 2 > balance Sheet > equity
1701492000
Quarters > 2 > cash Flow > net Income
-40456000
Quarters > 2 > cash Flow > depreciation
13953000
Quarters > 2 > cash Flow > change In Working Capital
7475000
Quarters > 2 > cash Flow > cash From Operations
13573000
Quarters > 2 > cash Flow > capital Expenditures
6578000
Quarters > 2 > cash Flow > cash From Investing
-137842000
Quarters > 2 > cash Flow > cash From Financing
-5154000
Quarters > 2 > cash Flow > net Change In Cash
-125571000
Quarters > 2 > ratios > PE
-0.8846322050205545
Quarters > 2 > ratios > PB
0.9487788364564747
Quarters > 2 > ratios > ROE
-2.3776779438281226
Quarters > 2 > ratios > ROA
-1.981267676334831
Quarters > 2 > ratios > FCF
6995000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.04877351517940565
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
147510000
Quarters > 3 > income Statement > cost Of Revenue
78839000
Quarters > 3 > income Statement > gross Profit
68671000
Quarters > 3 > income Statement > operating Expenses
80024000
Quarters > 3 > income Statement > operating Income
-11353000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-5852000
Quarters > 3 > income Statement > net Income
-13340000
Quarters > 3 > income Statement > eps
-0.29237715337746023
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
45626000
Quarters > 3 > income Statement > income Tax Expense
3569000
Quarters > 3 > income Statement > EBITDA
3332000
Quarters > 3 > income Statement > operating Margin
-7.696427360856892
Quarters > 3 > income Statement > total Other Income Expense Net
5501000
Quarters > 3 > balance Sheet > cash
377494000
Quarters > 3 > balance Sheet > short Term Investments
85951000
Quarters > 3 > balance Sheet > receivables
155038000
Quarters > 3 > balance Sheet > inventories
81006000
Quarters > 3 > balance Sheet > total Current Assets
846282000
Quarters > 3 > balance Sheet > property Plant Equipment
210126000
Quarters > 3 > balance Sheet > total Assets
2041210000
Quarters > 3 > balance Sheet > payables
31740000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
322244000
Quarters > 3 > balance Sheet > equity
1718966000
Quarters > 3 > cash Flow > net Income
-13340000
Quarters > 3 > cash Flow > depreciation
18100000
Quarters > 3 > cash Flow > change In Working Capital
19378000
Quarters > 3 > cash Flow > cash From Operations
30628000
Quarters > 3 > cash Flow > capital Expenditures
8580000
Quarters > 3 > cash Flow > cash From Investing
76256000
Quarters > 3 > cash Flow > cash From Financing
-5126000
Quarters > 3 > cash Flow > net Change In Cash
93447000
Quarters > 3 > ratios > PE
-0.29237715337746023
Quarters > 3 > ratios > PB
0.9369573336529052
Quarters > 3 > ratios > ROE
-0.7760479264860387
Quarters > 3 > ratios > ROA
-0.6535339333042656
Quarters > 3 > ratios > FCF
22048000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.1494678326893092
Quarters > 3 > health Score
48
Valuation > metrics > PE
69.75
Valuation > metrics > PB
0.9421685586387549
Valuation > final Score
40
Valuation > verdict
86.6% Overvalued
Profitability > metrics > ROE
2.735361056981998
Profitability > metrics > ROA
6.64243821462895
Profitability > metrics > Net Margin
0.2961015628926077
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.1935927894218237
Risk > metrics > Interest Coverage
0.4321436690156854
Risk > final Score
62
Risk > verdict
High
Liquidity > metrics > Current Ratio
18.81220507926409
Liquidity > metrics > Quick Ratio
16.825141827050526
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
60
Prev Risks > 1
55
Prev Risks > 2
55
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:15:35.836Z
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AIs Azenta’s US$250 Million Buyback And M&A Push Altering The Investment Case For AZTA? simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$39.8333
Analyst Picks
Strong Buy
1
Buy
1
Hold
5
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 79.43% of the total shares of Azenta Inc
1.
BlackRock Inc(16.3743%)
since
2025/06/30
2.
Politan Capital Management LP(10.0716%)
since
2025/06/30
3.
Vanguard Group Inc(9.954%)
since
2025/06/30
4.
Dimensional Fund Advisors, Inc.(5.9312%)
since
2025/06/30
5.
Conestoga Capital Advisors, LLC(4.1849%)
since
2025/06/30
6.
State Street Corp(3.9106%)
since
2025/06/30
7.
Allspring Global Investments Holdings, LLC(2.9347%)
since
2025/06/30
8.
GW&K Investment Management, LLC(2.7303%)
since
2025/06/30
9.
Millennium Management LLC(2.6164%)
since
2025/06/30
10.
Lord, Abbett & Co LLC(2.3644%)
since
2025/06/30
11.
Geode Capital Management, LLC(2.3221%)
since
2025/06/30
12.
Citadel Advisors Llc(2.3094%)
since
2025/06/30
13.
Morgan Stanley - Brokerage Accounts(2.0472%)
since
2025/06/30
14.
Palisade Capital Management LLc(1.8313%)
since
2025/06/30
15.
Stephens Inv Mgmt Group LLC(1.7609%)
since
2025/06/30
16.
American Capital Management Inc(1.7132%)
since
2025/06/30
17.
Park West Asset Management LLC(1.7097%)
since
2025/06/30
18.
Ameriprise Financial Inc(1.5763%)
since
2025/06/30
19.
Quantinno Capital Management LP(1.5575%)
since
2025/06/30
20.
Federated Hermes Inc(1.5283%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.